As a major pharmaceutical company that is constantly innovating and developing new treatments, Eli Lilly (NYSE: LLY) is ...
Risk adjusted net present value: What is the current valuation of Eli Lilly and Co’s Eloralintide?
Eloralintide is a synthetic peptide commercialized by Eli Lilly and Co, with a leading Phase II program in Obesity.
Mazisotine is a small molecule commercialized by Eli Lilly and Co, with a leading Phase II program in Diabetic Neuropathic Pain.
Eli Lilly (LLY 0.86%) and Novo Nordisk (NVO -1.53%) have competed for decades. They're both leaders in the areas of insulin ...
With drugs like Novo Nordisk's Wegovy becoming household names over the last couple of years, it's no surprise that there are ...
Some stocks sizzle, then fizzle. Others, though, build long-lasting momentum thanks to strong underlying business ...
Indiana’s Governor Eric Holcomb says he’s reflecting on his time as Governor now that it’s about to come to an end next month ...
President-elect Donald Trump set two tables for a dinner party this month with his choice for Health and Human Services ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback